BENDAMUSTINE, FOLLOWED BY OBINUTUZUMAB, ACALABRUTINIB AND VENETOCLAX IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) : CLL2‐BAAG TRIAL OF THE GCLLSG
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
Hematological Oncology - 39(2021) |
Beteiligte Personen: |
Cramer, P [VerfasserIn] |
---|
BKL: |
---|
Anmerkungen: |
© 2021 John Wiley & Sons Ltd. |
---|
doi: |
10.1002/hon.34_2879 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
WLY007119577 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | WLY007119577 | ||
003 | DE-627 | ||
005 | 20230307165131.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230216s2021 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1002/hon.34_2879 |2 doi | |
028 | 5 | 2 | |a HON_HON34_2879.xml |
035 | |a (DE-627)WLY007119577 | ||
035 | |a (WILEY)HON34_2879 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.81 |2 bkl | ||
084 | |a 44.86 |2 bkl | ||
100 | 1 | |a Cramer, P |e verfasserin |4 aut | |
245 | 1 | 0 | |a BENDAMUSTINE, FOLLOWED BY OBINUTUZUMAB, ACALABRUTINIB AND VENETOCLAX IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |b CLL2‐BAAG TRIAL OF THE GCLLSG |
264 | 1 | |c 2021 | |
300 | |a 0 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © 2021 John Wiley & Sons Ltd. | ||
700 | 1 | |a Fürstenau, M |4 aut | |
700 | 1 | |a Robrecht, S |4 aut | |
700 | 1 | |a Giza, A |4 aut | |
700 | 1 | |a Fink, A. M |4 aut | |
700 | 1 | |a Fischer, K |4 aut | |
700 | 1 | |a Langerbeins, P |4 aut | |
700 | 1 | |a Al Sawaf, O |4 aut | |
700 | 1 | |a Tausch, E |4 aut | |
700 | 1 | |a Schneider, C |4 aut | |
700 | 1 | |a Schetelig, J |4 aut | |
700 | 1 | |a Dreger, P |4 aut | |
700 | 1 | |a Böttcher, S |4 aut | |
700 | 1 | |a Kreuzer, K. A |4 aut | |
700 | 1 | |a Schilhabel, A |4 aut | |
700 | 1 | |a Brüggemann, M |4 aut | |
700 | 1 | |a Kneba, M |4 aut | |
700 | 1 | |a Wendtner, C. M |4 aut | |
700 | 1 | |a Stilgenbauer, S |4 aut | |
700 | 1 | |a Eichhorst, B |4 aut | |
700 | 1 | |a Hallek, M |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Hematological Oncology |g 39(2021) |w (DE-627)WLY00710880X |x 10991069 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:2021 |g extent:0 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_WLY | ||
936 | b | k | |a 44.81 |q ASE |
936 | b | k | |a 44.86 |q ASE |
951 | |a AR | ||
952 | |d 39 |j 2021 |g 0 |